Biblio Discovery — Demo Discovery Service

10 hasil untuk "Kavitha Gowrishankar"

Menampilkan 1–10 · 0,30 detik · RSS

  1. Artikel Jurnal

    Navigating CAR-T translation in Australia: lessons from an academic program

    Rui Ping Amanda Tan; Robyn Walsh; Geoffrey McCowage dkk.

    Frontiers in Medicine, Vol. 13 · 2026 · Inggris · DOAJ Scopus

    Adoptive cell therapies utilizing both gene-modified and unmodified immune cells have revolutionized treatments for cancer and infection. Seven Chimeric antigen receptor (CAR) T cell products have been approved as therapies, providing the momentum to expand their clinical benefit to several cancer…

  2. Artikel Jurnal

    Evolving Strategies to Eliminate the CD4 T Cells HIV Viral Reservoir via CAR T Cell Immunotherapy

    Jarrod York; Kavitha Gowrishankar; Kenneth Micklethwaite dkk.

    Frontiers in Immunology, Vol. 13 · 2022 · Inggris · DOAJ Scopus

    Although the advent of ART has significantly reduced the morbidity and mortality associated with HIV infection, the stable pool of HIV in latently infected cells requires lifelong treatment adherence, with the cessation of ART resulting in rapid reactivation of the virus and productive HIV…

  3. Artikel Jurnal Teks lengkap

    Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-κB

    Kavitha Gowrishankar; Dilini Gunatilake; Stuart J. Gallagher dkk.

    PLOS ONE, Vol. 10 No. 4 · 2015 · Inggris · PLOS Scopus

    Monoclonal antibodies against immune checkpoint blockade have proven to be a major success in the treatment of melanoma. The programmed death receptor-1 ligand-1 (PD-L1) expression on melanoma cells is believed to have an inhibitory effect on T cell responses and to be an important escape mechanism…

    Juga tersedia di: DOAJ

  4. Artikel Jurnal

    Current developments in T-cell receptor therapy for acute myeloid leukemia

    Sayali Gore; Emily Blyth; Marie Bleakley dkk.

    Blood Advances, Vol. 9 No. 12 · 2025 · Inggris · DOAJ Scopus

    Abstract: T-cell receptor (TCR) therapies are a promising modality for the treatment of cancers, with significant efforts being directed toward acute myeloid leukemia (AML), a particularly challenging disease. Chimeric antigen receptor (CAR) T cells targeting single surface antigens have shown…

  5. Bab Buku Teks lengkap

    Acquired Resistance to Targeted MAPK Inhibition in Melanoma

    Kavitha Gowrishankar; Matteo S. Carlino; Helen Rizos

    Melanoma - From Early Detection to Treatment · 2013 · Inggris · IntechOpen

  6. Artikel Jurnal

    CAR T Cell Generation by piggyBac Transposition from Linear Doggybone DNA Vectors Requires Transposon DNA-Flanking Regions

    David C. Bishop; Lisa Caproni; Kavitha Gowrishankar dkk.

    Molecular Therapy: Methods & Clinical Development, Vol. 17 · 2020 · Inggris · DOAJ

    CD19-specific chimeric antigen receptor (CAR19) T cells, generated using viral vectors, are an efficacious but costly treatment for B cell malignancies. The nonviral piggyBac transposon system provides a simple and inexpensive alternative for CAR19 T cell production. Until now, piggyBac has been…

  7. Artikel Jurnal

    Characterizing piggyBat—a transposase for genetic modification of T cells

    Gaurav Sutrave; Ning Xu; Tiffany C.Y. Tang dkk.

    Molecular Therapy: Methods & Clinical Development, Vol. 25 · 2022 · Inggris · DOAJ

    Chimeric antigen receptor (CAR) T cells targeting CD19 have demonstrated remarkable efficacy in the treatment of B cell malignancies. Current CAR T cell manufacturing protocols are complex and costly due to their reliance on viral vectors. Non-viral systems of genetic modification, such as with…

  8. Artikel Jurnal

    Ex vivo enrichment of PRAME antigen‐specific T cells for adoptive immunotherapy using CD137 activation marker selection

    Koon H Lee; Kavitha Gowrishankar; Janine Street dkk.

    Clinical & Translational Immunology, Vol. 9 No. 10 · 2020 · Inggris · DOAJ Scopus

    Abstract Objective Adoptive immunotherapy with ex vivo expanded tumor‐specific T cells has potential as anticancer therapy. Preferentially expressed antigen in melanoma (PRAME) is an attractive target overexpressed in several cancers including melanoma and acute myeloid leukaemia (AML), with low…

  9. Artikel Jurnal

    CAR+ and CAR− T cells share a differentiation trajectory into an NK-like subset after CD19 CAR T cell infusion in patients with B cell malignancies

    Raymond Hall Yip Louie; Curtis Cai; Jerome Samir dkk.

    Nature Communications, Vol. 14 No. 1 · 2023 · Inggris · DOAJ Scopus

    Abstract Chimeric antigen receptor (CAR) T cell therapy is effective in treating B cell malignancies, but factors influencing the persistence of functional CAR+ T cells, such as product composition, patients’ lymphodepletion, and immune reconstitution, are not well understood. To shed light on this…